About Us
News
Products
R & D
Careers
Responsibility
Partnering
Manufacture
En
中
Home
About Us
About Simcere
Management
Milestones
Culture
Contact Us
News
Products
R & D
Research Overview
Pipeline
Global layout
local partner
Careers
Responsibility
Partnering
Current Partnership
Interest
Contact
Manufacture
中文
News
News
Simcere won seven honors in 2018 China Chemical-pharmaceutical Industry Outstanding Enterprises and Excellent Product Brand List
Simcere won seven honors in 20...
Time：October22,2018
On October 16, 2018, the 2018' China Chemical-PharmaceuticalIndustry Annual Summit was held in Nanjing. During the conference, the China Chemical-pharmaceuticalIndustry Outstanding Enterprises and...
On October 16, 2018, the 2018' China Chemical-Pharmaceut...
Simcere's Montmorillonite (Biqi) passed Quality Consistency Evaluation for Generic Drugs
Simcere's Montmorillonite (Biq...
Time：July10,2018
According to the database of the State Foodand Drug Administration, "Biqi®-Montmorillonite Powder" manufactured by Simcere Pharmaceutical(Hainan) Co., Ltd. is among the first batc...
According to the database of the State Foodand Drug Administ...
Meet Simcere at Boston Simcere Night
Meet Simcere at Boston Simcere...
Time：May23,2018
Dear Friends,This is our sincere invitation to a night of fun event at Boston US on 5th of June 2018 for you to know Simcere better.Please scan the QR code to resister for 2018 CABA/CBA Biopharma Foru...
Dear Friends,This is our sincere invitation to a night of fu...
Merus executive team visit Simcere headquarter
Merus executive team visit Si...
Time：May23,2018
On May 21, 2018, the executive team of Meruslead by Dr. Ton Logtenberg, CEO of Merus visited the headquarter of Simcere. This is the first time this European biotech visitSimcere since the two parti...
On May 21, 2018, the executive team of Meruslead by Dr. Ton ...
Endostar included in " CSCO Guidelines on the Diagnosis and Treatment of Conventional Osteosarcoma”(2018 Edition) first-line treatment recommendation
Endostar included in " CSCO Gu...
Time：April25,2018
On April 22, 2018, the First Edition of 《Chinese Society of Clinical Oncology (CSCO)Guidelines on the Diagnosis and Treatment of Conventional Osteosarcoma (2018Edition)》 wasformally released at the...
On April 22, 2018, the First Edition of 《Chinese Society of ...
Simcere Announces Research Collaboration and License Agreement with HitGen
Simcere Announces Research Col...
Time：April25,2018
On Apr 20, 2018, Simcere Pharmaceutical Group (Simcere) and HitGen Ltd(HitGen) announced that they have entered into a license agreement oninnovative drug discovery. Based on the multi-year research...
On Apr 20, 2018, Simcere Pharmaceutical Group (Simcere) and ...
Prev page
1
...
9
Next page
